Visit COVID-19 resources

[Skip to Content]

Response to ‘Comment on Topiramate maculopathy secondary to dose titration: first reported case’ – (Eye 30, 166 (January 2016))

7 January 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login